Published On: Wed, Oct 19th, 2016

Analyst Review: IMS Health Holdings, Inc. (NYSE:IMS)


A number of investment brokers have recently updated their price targets on shares of IMS Health Holdings, Inc. (NYSE:IMS).

Most recent broker ratings

05/12/2016 – IMS Health Holdings, Inc. was downgraded to “market perform” by analysts at Wells Fargo.

05/04/2016 – IMS Health Holdings, Inc. had its “buy” rating reiterated by analysts at Topeka Capital Markets. They now have a USD 30 price target on the stock.

03/24/2016 – IMS Health Holdings, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 32 price target on the stock.

02/24/2016 – IMS Health Holdings, Inc. had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 31 price target on the stock.

02/04/2016 – IMS Health Holdings, Inc. had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 29 price target on the stock.

02/04/2016 – IMS Health Holdings, Inc. had its “equal weight” rating reiterated by analysts at Barclays. They now have a USD 26 price target on the stock.

10/30/2015 – IMS Health Holdings, Inc. had its “buy” rating reiterated by analysts at Mizuho. They now have a USD 33 price target on the stock.

08/03/2015 – IMS Health Holdings, Inc. had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 37 price target on the stock.

03/21/2015 – IMS Health Holdings, Inc. had its “neutral” rating reiterated by analysts at Robert W. Baird. They now have a USD 28 price target on the stock.

02/05/2015 – UBS began new coverage on IMS Health Holdings, Inc. giving the company a “neutral” rating. They now have a USD 27 price target on the stock.

12/19/2014 – IMS Health Holdings, Inc. had its “equal weight” rating reiterated by analysts at Morgan Stanley. They now have a USD 28 price target on the stock.

08/05/2014 – IMS Health Holdings, Inc. had its “neutral” rating reiterated by analysts at Goldman Sachs. They now have a USD 26 price target on the stock.

08/05/2014 – Drexel Hamilton began new coverage on IMS Health Holdings, Inc. giving the company a “buy” rating. They now have a USD 30 price target on the stock.

05/14/2014 – JP Morgan began new coverage on IMS Health Holdings, Inc. giving the company a “overweight” rating. They now have a USD 28 price target on the stock.

05/14/2014 – SunTrust began new coverage on IMS Health Holdings, Inc. giving the company a “neutral” rating. They now have a USD 25 price target on the stock.

The share price of IMS Health Holdings, Inc. (NYSE:IMS) was up +0.00% during the last day of trading, with a day high of 0.00. 0 shares were traded during the last session.

The stock’s 50 day moving average is 30.48 and its 200 day moving average is 27.78.IMS Health Holdings, Inc. has a 52-week low of 22.36 and a 52-week high of 31.59.

IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company’s principal information offerings include national information offerings, sub-national information offerings and OneKey. Its technology services offerings include technology solutions, real-world evidence solutions, and workflow analytics and consulting services. It offers technology services that include data warehousing, information technology (IT) outsourcing, software applications and other services.